Opthea Ltd
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Non-accelerated filerEmerging growth company
State of Incorporation
Australia
Country
Australia
Business Address
LEVEL 4, SOUTH YARRA, , 3141
Mailing Address
LEVEL 4, SOUTH YARRA, , 3141
Phone
61 3 9826 0399
Fiscal Year End
0630
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | November 20, 2025 | View on SEC |
| 6-K Foreign company current report | November 12, 2025 | View on SEC |
| 6-K Foreign company current report | October 31, 2025 | View on SEC |
| 6-K Foreign company current report | October 30, 2025 | View on SEC |
| 6-K Foreign company current report | October 27, 2025 | View on SEC |
| 6-K Foreign company current report | October 10, 2025 | View on SEC |
| 6-K Foreign company current report | October 6, 2025 | View on SEC |
| 6-K Foreign company current report | September 15, 2025 | View on SEC |
| 20-F Foreign company annual report | September 15, 2025 | View on SEC |
| 6-K Foreign company current report | August 29, 2025 | View on SEC |
Annual Reports
20-F
September 15, 2025
- Phase 3 trial success for soletorasertib demonstrating efficacy and reduced injection frequency
- Teamed up with a manufacturing partner to scale production
Related Companies
Companies in the same industry (SIC: 2836)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
CERO THERAPEUTICS HOLDINGS, INC.
CERO
Biological Products, (No Diagnostic Substances)
BioCardia, Inc.
BCDA
Biological Products, (No Diagnostic Substances)
Mosaic ImmunoEngineering Inc.
CPMV
Biological Products, (No Diagnostic Substances)
Abpro Holdings, Inc.
ABPO
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.